-
Methylprednisolone Shows No Clear Benefit for FA Patients in Pilot Trial
Treatment with methylprednisolone had no evident benefit for 11 children and adults with Friedreich’s ataxia enrolled in a pilot clinical trial. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.